-
Tue23Apr2024Thu25Apr2024
-
Sun28Apr2024
-
Thu02May2024Sat04May2024
-
Thu09May2024Philadelphia, United States
-
Thu23May2024Fri24May2024
-
Sun26May2024Tue28May2024
-
Tue28May2024Fri31May2024
-
Fri14Jun2024Sat15Jun2024
Latest News
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB)...
Features
REBOA: Is balloon use in emergency trauma really just hot air?
Balloon occlusion is one of the most hotly contested topics when it comes to vascular surgery in the setting of emergency trauma and, with...
New data and heated debates set to spark controversy in CX...
“These will be important, salutary lessons. Should a controversy arise again involving a proven efficacious therapy, we now know that stopping access to that...
Videos
In a recent interview, Marie Josee van Rijn from Rotterdam, the Netherlands and Emma Wilton from Oxford, UK, provided insight into the transformative power of interventional approaches in the treatment of DVT. They also set the stage for the...
